Rachel E. Johns

Most-cited papers

1. Targeted tissue delivery of RNA therapeutics using antibody–oligonucleotide conjugates (AOCs)

   Barbora Malecova, Rob S. Burke, Michael Cochran, Michael Hood +11 more

   2023Nucleic Acids Research131 citations Open access

   Semantic Scholar

   Save

2. Improved specificity of gene silencing by siRNAs containing unlocked nucleobase analogs

   N. Vaish, Feng Chen, S. Seth, K. Fosnaugh +12 more

   2010Nucleic Acids Research104 citations Open access

   Semantic Scholar

   Save

3. Electricity-Free Amplification and Detection for Molecular Point-of-Care Diagnosis of HIV-1

   Jered Singleton, Jennifer L. Osborn, Lorraine Lillis, Kenneth R. Hawkins +7 more

   2014PLoS ONE72 citations Open access

   Semantic Scholar

   Save

4. RNAi-based therapeutics targeting survivin and PLK1 for treatment of bladder cancer.

   S. Seth, Y. Matsui, K. Fosnaugh, Yan Liu +21 more

   2011Molecular Therapy56 citations Open access

   Semantic Scholar

   Save

5. Delivery and biodistribution of siRNA for cancer therapy: challenges and future prospects.

   S. Seth, Rachel E. Johns, M. Templin

   2012Therapeutic delivery53 citations

   Semantic Scholar

   Save

6. An amino acid-based amphoteric liposomal delivery system for systemic administration of siRNA.

   R. Adami, S. Seth, P. Harvie, Rachel E. Johns +17 more

   2011Molecular Therapy49 citations Open access

   Semantic Scholar

   Save

7. Differential monocyte/macrophage interleukin-1β production due to biomaterial topography requires the β2 integrin signaling pathway.

   A. Collie, Paige C. S. Bota, Rachel E. Johns, R. Maier +1 more

   2011Journal of Biomedical Materials Research. Part A28 citations

   Semantic Scholar

   Save

8. Disposition and Oral Bioavailability in Rats of an Antiviral and Antitumor Amino Acid Phosphoramidate Prodrug of AZT-Monophosphate

   Heng Song, Rachel E. Johns, G. Griesgraber, C. Wagner +1 more

   2003Pharmaceutical Research11 citations

   Semantic Scholar

   Save

9. Mechanistic analysis of macrophage response to IRAK-1 gene knockdown by a smart polymer-antisense oligonucleotide therapeutic

   Rachel E. Johns, M. El-Sayed, V. Bulmus, J. Cuschieri +3 more

   2008Journal of Biomaterials Science. Polymer Edition7 citations

   Semantic Scholar

   Save

10. Development of a DUX4-targeting antibody oligonucleotide conjugate as a therapy for FSHD

    Barbora Malecova, Davide Sala, G. M. Melikian, Rachel E. Johns +12 more

    2026Nucleic Acids Research5 citations Open access

    Semantic Scholar

    Save

11. 639. Gene Expression Analysis of LPS Stimulated THP-1 Cells Treated with Antisense IRAK1 Delivered Using a pH-Sensitive, Membrane Disruptive Polymer

    Rachel E. Johns, A. Hoffman, P. Stayton

    20041 citations Open access

    Semantic Scholar

    Save

12. Abstract 281: Novel nucleic acid constructs and formulations for treatment of bladder cancer and malignant ascites

    Yan Liu, Yan Chen, K. Fosnaugh, S. Seth +12 more

    20120 citations

    Semantic Scholar

    Save

13. Abstract 581: Development of RNA interference-based therapeutics for bladder cancer and hepatocellular carcinoma

    K. Fosnaugh, S. Seth, Y. Matsui, R. Adami +13 more

    20100 citations

    Semantic Scholar

    Save

14. Process and compositions for liposomal and effective delivery of nucleicacids

    B. Polisky, R. Adami, M. Templin, P. Harvie +3 more

    20090 citations

    Semantic Scholar

    Save